Rosiglitazone enhances the radiosensitivity of p53-mutant HT-29 human colorectal cancer cells.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2010-04-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbrc.2010.03.068PMID 20227390
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The PI3-K/AKT-Pathway and Radiation Resistance Mechanisms in Non-small Cell Lung Cancer

  2009cited by this paper
• Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells

  2009cited by this paper
• Rosiglitazone and PPAR‐γ overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti‐apoptotic Bcl‐2 family proteins

  2009cited by this paper
• Ligand-Activated Peroxisome Proliferator–Activated Receptor-γ Protects Against Ischemic Cerebral Infarction and Neuronal Apoptosis by 14-3-3&egr; Upregulation

  2009cited by this paper
• A critical role for AKT activation in protecting cells from ionizing radiation-induced apoptosis and the regulation of acinus gene expression.

  2009cited by this paper
• Gefitinib Radiosensitizes Non–Small Cell Lung Cancer Cells by Suppressing Cellular DNA Repair Capacity

  2008cited by this paper
• Radiosensitization of cervical cancer cells via double-strand DNA break repair inhibition.

  2008cited by this paper
• Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.

  2008cited by this paper
• Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3

  2008cited by this paper
• Thiazolidinediones as anti-cancer agents.

  2008cited by this paper
• γH2AX and cancer

  2008cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Regression of Drug-Resistant Lung Cancer by the Combination of Rosiglitazone and Carboplatin

  2008cited by this paper
• Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells.

  2008cited by this paper
• Induction of genetic instability by gain-of-function p53 cancer mutants

  2008cited by this paper
• Upregulation of PTEN involved in rosiglitazone-induced apoptosis in human hepatocellular carcinoma cells

  2007cited by this paper
• Radiation-induced cell signaling: inside-out and outside-in

  2007cited by this paper
• Rosiglitazone enhances fluorouracil-induced apoptosis of HT-29 cells by activating peroxisome proliferator-activated receptor gamma.

  2007cited by this paper
• The concurrent chemoradiation paradigm—general principles

  2007cited by this paper
• Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-alpha, CH11 and CYC202.

  2007cited by this paper
• γH2AX as a Checkpoint Maintenance Signal

  2006cited by this paper
• A phosphatase complex that dephosphorylates γH2AX regulates DNA damage checkpoint recovery

  2006cited by this paper
• The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

  2006cited by this paper
• Rosiglitazone inhibits endothelial proliferation and angiogenesis.

  2006cited by this paper
• gammaH2AX as a checkpoint maintenance signal.

  2006cited by this paper
• Peroxisome Proliferator-activated Receptor γ Agonists Promote TRAIL-induced Apoptosis by Reducing Survivin Levels via Cyclin D3 Repression and Cell Cycle Arrest*

  2005cited by this paper
• Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.

  2005cited by this paper
• Peroxisome proliferator-activated receptor γ ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines

  2005cited by this paper
• Induction of apoptosis in colorectal cancer cells by peroxisome proliferators-activated receptor gamma activation up-regulating PTEN and inhibiting PI3K activity.

  2005cited by this paper
• Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest.

  2005cited by this paper
• Role of cell cycle in mediating sensitivity to radiotherapy.

  2004cited by this paper
• Enhancement of radiation response by roscovitine in human breast carcinoma in vitro and in vivo.

  2003cited by this paper
• Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002.

  2003cited by this paper
• Dominant-negative cAMP-responsive Element-binding Protein Inhibits Proliferating Cell Nuclear Antigen and DNA Repair, Leading to Increased Cellular Radiosensitivity*

  2003cited by this paper
• MAPK pathways in radiation responses

  2003cited by this paper
• Adjuvant therapy of cancers of the colon and rectum.

  2002cited by this paper
• MEK/ERK pathway protects ionizing radiation-induced loss of mitochondrial membrane potential and cell death in lymphocytic leukemia cells

  2002cited by this paper
• Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.

  2000cited by this paper
• DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139*

  1998cited by this paper

• Nuclear receptors as novel regulators that modulate cancer radiosensitivity and normal tissue radiotoxicity

  2025cites this paper
• PI3K/AKT/mTOR Targeting in Colorectal Cancer Radiotherapy: A Systematic Review

  2025cites this paper
• Thiazolidinedione derivatives in cancer therapy: exploring novel mechanisms, therapeutic potentials, and future horizons in oncology

  2024cites this paper
• A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies

  2023cites this paper
• The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells

  2020cites this paper
• The PPAR γ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells

  2020cites this paper
• The Treatment of Heterotopic Human Colon Xenograft Tumors in Mice with 5-Fluorouracil Attached to Magnetic Nanoparticles in Combination with Magnetic Hyperthermia Is More Efficient than Either Therapy Alone

  2020cites this paper
• Study of the antitumor mechanisms of apiole derivatives (AP-02) from Petroselinum crispum through induction of G0/G1 phase cell cycle arrest in human COLO 205 cancer cells

  2019cites this paper
• An adenosine derivative (IFC-305) reduced the risk of radiation-induced intestinal toxicity in the treatment of colon cancer by suppressing the methylation of PPAR-r promoter.

  2019cites this paper
• miR‐16‐5p modulates the radiosensitivity of cervical cancer cells via regulating coactivator‐associated arginine methyltransferase 1

  2019cites this paper
• Thiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: A meta-analysis

  2018cites this paper
• Research Advances in the Correlation between Peroxisome Proliferator-Activated Receptor-γ and Digestive Cancers

  2018cites this paper
• New insights into molecular mechanisms of rosiglitazone in monotherapy or combination therapy against cancers.

  2018cites this paper
• Rosiglitazone Role in the Expression of KLF6 Caco-2 Colon Cancer Cells

  2017cites this paper
• New insights into antidiabetic drugs: Possible applications in cancer treatment

  2017cites this paper
• Rosiglitazone enhances radiosensitivity by inhibiting repair of DNA damage in cervical cancer cells

  2017cites this paper
• The Impact of Post-Translational Regulation of Histone on Cancer Metastasis and Cancer Chemoresistance

  2017cites this paper
• A PPAR-gamma agonist protects from radiation-induced intestinal toxicity

  2017cites this paper
• Arginine starvation in colorectal carcinoma cells: Sensing, impact on translation control and cell cycle distribution.

  2016cites this paper
• Radiosensitizing potential of rutin against human colon adenocarcinoma HT-29 cells.

  2016cites this paper
• Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells

  2015cites this paper
• Antihyperglycaemic therapies and cancer risk

  2014cites this paper
• A new dawn for the use of thiazolidinediones in cancer therapy

  2014cites this paper
• Effects of rosiglitazone on the growth and lymphangiogenesis of human gastric cancer transplanted in nude mice.

  2013cites this paper
• The Tumor Suppressor, p53, Contributes to Radiosensitivity of Lung Cancer Cells by Regulating Autophagy and Apoptosis

  2013cites this paper
• Use of thiazolidinedione and cancer risk in Type 2 diabetes: the Hong Kong diabetes registry.

  2012cites this paper
• Cyclic phosphatidic acid decreases proliferation and survival of colon cancer cells by inhibiting peroxisome proliferator‐activated receptor γ

  2010cites this paper
• Oncotargets and Therapy Dovepress Dovepress Mir-195 Enhances the Radiosensitivity of Colorectal Cancer Cells by Suppressing Carm1

  year unknowncites this paper